Diabetic ketoacidosis Cells in the human body normally use glucose as their major source of energy. IDDM , C-peptide negative Diabetic ketoacidosis , with or without coma Severe hepatic function disorder Concomitant use of gemfibrozil see section 4. Dehydration is another complication of DKA. DKA often leads to people being newly diagnosed with type 1 diabetes.
|Published (Last):||19 January 2016|
|PDF File Size:||7.60 Mb|
|ePub File Size:||12.84 Mb|
|Price:||Free* [*Free Regsitration Required]|
Hine et coll. Endocr Rev 32 [Medline] S. Delineation of the major renal reabsorptive mechanism for D-glucose. Weir Diabetic ketoacidosis, sodium glucose transporter-2 inhibitors and the kidney. Scheen SGLT2 inhibition : efficacy and safety in type 2 diabetes treatment. Ferrannini Euglycemic diabetic ketoacidosis : a predictable, detectable, and preventable safety concern with sglt2 inhibitors. Sakaguchi Euglycemic diabetic ketoacidosis induced by SGLT2 inhibitors : possible mechanism and contributing factors.
N Engl J Med Invokana, Invokamet to include updates on bone fracture risk and new information on decreased bone mineral density. T Hayami Y Kato H Kamiya Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet. Herring SGLT inhibition and euglycaemic diabetic ketoacidosis. Lancet Diabetes Endocrinol 3 [Medline] S.
Announcement www. Euglycemic diabetic ketoacidosis : a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care 38 [Medline]. Contact auteur s.
Le coma acido-cetosique
Fesar Copy code to clipboard. A firewall is blocking access to Prezi content. Check if you have access through your login credentials or your institution. Delete comment or cancel. Send link to edit together this prezi using Prezi Meeting learn more: Invited audience members will follow you as acidocetose diabetique navigate and present People invited to a presentation do not acidocetose diabetique a Prezi account This link expires 10 minutes after you close the presentation A maximum of acidocetose diabetique users can follow your presentation Learn more about this feature in our knowledge base article.
Physiopathologie de l’Acidocétose Diabétique